Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience
Authors: Francois Panet, Matt Young, Stephanie Wong, Alice Dragomir, April A. N. Rose, Lawrence Panasci